European equities traded in the US as American depositary receipts were little changed late Friday morning with the S&P Europe Select ADR Index rising less than 0.1% to 1,520.44.

From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and semiconductor company Sequans Communications (SQNS), which advanced 10% and 7% respectively. They were followed by biopharmaceutical company Genfit (GNFT) and biotech company Evaxion (EVAX), which climbed 5.7% and 4.5% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and pharmaceutical company Novo Nordisk (NVO), which dropped 4.5% and 2.1% respectively. They were followed by oil and gas company Eni (E) and petroleum refiner Equinor (EQNR), which lost 1.9% and 1.5% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and software firm Endava (DAVA), which rose 3.1% and 2.2% respectively. They were followed by hospitality company InterContinental Hotels Group (IHG) and utilities company National Grid (NGG), which were up 1.6% and 1.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and financial services company Barclays (BCS), which fell 5.7% and 2% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and oil and gas company BP (BP), which were down 1.7% each.